midi compounded semaglutide + B12 - Weight Loss Compounded Microdose Semaglutide

Mar 2019;282:196-201

As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60

68 However, another murine model did not report these changes

A crucial step is to understand the companys target patient populations through the lens of GLP-1 use